Search Results
32. Cover letter attachments for controlled correspondence and ANDA submissions: guidance for industry
33. Delays in confirmatory trials for drug applications granted FDA’s accelerated approval raise concerns
- « Previous
- Next »
- 1
- 2
- 3
- 4